Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma.

Condition:   Resectable Gastric and Gastroesophageal Junction Adenocarcinoma
Interventions:   Drug: Fluorouracil;   Drug: Oxaliplatin;   Drug: Irinotecan
Sponsor:   Lund University Hospital
Not yet recruiting

https://ift.tt/2EuaaFG